Cannabidiol (CBD): Discussing Benefits and Risks with Patients episode artwork

EPISODE · Jun 28, 2022 · 29 MIN

Cannabidiol (CBD): Discussing Benefits and Risks with Patients

from Mayo Clinic Talks · host Mayo Clinic

Guest: Thomas P. Pittelkow, D.O., M.P.H. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Cannabidiol (CBD) is a popular natural remedy used for a variety of common ailments and is one of more than 100 chemical compounds called cannabinoids derived from the cannabis plant. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis. However, unlike THC, CBD does not have psychoactive properties. There are claims this compound treats not only pain, but a variety of mental health issues, symptoms of malignancy and may even have some cardiovascular benefits. Are all these claims true? What’s been proven? What do we know about the safety of this product? We’ll get the answers to these questions as we discuss Cannabidiol (CBD) with Thomas P. Pittelkow, D.O., M.P.H., an anesthesiologist and pain medicine specialist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Episode metadata supplied by the publisher feed · Published Jun 28, 2022

Embed this episode

NOW PLAYING

Cannabidiol (CBD): Discussing Benefits and Risks with Patients

0:00 29:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Mayo Clinic Talks?

This episode is 29 minutes long.

When was this Mayo Clinic Talks episode published?

This episode was published on June 28, 2022.

Can I download this Mayo Clinic Talks episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!